MAPS Canada’s Data Breach Foreshadows Corporadelic Future

As the psychedelic pharmaceutical industry increasingly prioritizes personal data extraction through mobile apps, wearables, and so-called “targeted” medicine, a recent data breach by former MAPS Canada Executive Director Mark Haden provides a warning about some of the possible consequences to the financial incentives of datafication.


#25 – Press Release: Plus Three found to have neuroprotective effects against corporadelic BS

In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements. We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are superior to (and safer than) psilocybin (one of the safest psychoactive compounds in the human pharmacopoeia), to students who claimed Oreos were as addictive as cocaine, to pineal DMT, cold fusion, and more.


Psychedelic Media Should Stop Parroting Corporate Press Releases

When the media republishes statements from psychedelic pharmaceutical startups and their executives with little-to-no vetting, it functions as a corporate megaphone and damages the field of psychedelic science.


DARE to Resist White Supremacy and The Police

American policing is a white supremacist institution that has repeatedly demonstrated the degree to which it values property over human life. Our struggles against the police are inseparably entwined with similar struggles around the world, and they cannot be disconnected from larger struggles for human rights.


Turn Off Your Mind, Relax—and Float Right-Wing?

On January 6th, 2021 at least two psychedelic heads stormed the United States Capitol. Strange as it may seem, those adhering to right-wing politics haven’t just established a beachhead in the psychedelic renaissance—they’re maneuvering to own it.


COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health Conditions Than You Can Name

News that COMPASS Pathways is attempting to patent psychedelic therapy room specifications and therapist behaviors started an online firestorm about the company’s “monopolistic and shady behaviors,” but so far the debates have missed the biggest threats lurking in COMPASS’s international patent applications.


#46 – Part One: Right Wing Psychedelia

We discuss Brian Pace and Neşe Devenot's recently published paper: "Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency" 


#47 – Part Two: Right Wing Psychedelia

We continue our discussion about Brian Pace and Neşe Devenot's recently published paper: "Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency" 


#48 – Drugs and Anti-Capitalism with Hilary Agro

We talk drugs and anti-capitalism with anthropology PhD candidate, Hilary Agro. Ranging from prohibition to psychedelic clinical trials and beyond, we explore the overlaps and differences in our analyses of the current psychedelic (and broader drug policy) landscape.


Bicycle Day 2020 Was Truly Historic, But Not for the Reasons You Think

Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”